Metraipolis › archive › dc_e93010bee07b

Avelumab — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Avelumab
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-10T12:38:40.191Z
SHA-256 of the archived text
77c5fc2eeed63b726ad5d58fa9f0a72d83c274bfc8cd1a08c7ec4aef70af96ca
Stable URL of this page
https://metraipolis.com/documento/dc_e93010bee07b

How to cite

Avelumab — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Avelumab (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_e93010bee07b (Metraipolis archive dc_e93010bee07b, sha256 77c5fc2eeed63b726ad5d58fa9f0a72d83c274bfc8cd1a08c7ec4aef70af96ca)
BibTeX
@misc{dce93010bee07b,
  title = {Avelumab — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Avelumab},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_e93010bee07b; sha256 77c5fc2eeed63b726ad5d58fa9f0a72d83c274bfc8cd1a08c7ec4aef70af96ca},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Avelumab. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Avelumab, sold under the brand name Bavencio, is a fully human monoclonal antibody medication for the treatment of Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. Common side effects include fatigue, musculoskeletal pain, diarrhea, nausea, infusion-related reactions, rash, decreased appetite and swelling of the limbs (peripheral edema). Avelumab targets the protein programmed death-ligand 1 (PD-L1). It has received orphan drug designation by the European Medicines Agency (EMA) for the treatment of gastric cancer in January 2017. The US Food and Drug Administration (FDA) approved it in March 2017, for the treatment of Merkel-cell carcinoma, an aggressive type of skin cancer. The EMA approved it in September 2017, for the same indication. This is the first FDA-approved treatment for metastatic Merkel-cell carcinoma, a rare, aggressive form of skin cancer. Avelumab was developed by Merck KGaA and Pfizer.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Avelumab» — https://en.wikipedia.org/wiki/Avelumab
Wikidata Q21083261: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q21083261
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Avelumab?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1292952219, consultata il 2026-11-10T12:35:11.769Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 9e9cb5178f602385f33b3f43dca9c80a90e1083abdeb13e72bce79f2f8fdaca8